Front. Cardiovasc. Med.Frontiers in Cardiovascular MedicineFront. Cardiovasc. Med.2297-055XFrontiers Media S.A.10.3389/fcvm.2024.1494278Cardiovascular MedicineEditorialEditorial: Proven and innovative methods of ex vivo examination of atherosclerotic and aortic valve lesionsTorzewskiMichael1*FanJianglin2MalashichevaAnna3Department of Laboratory Medicine and Hospital Hygiene, Robert Bosch Hospital, Stuttgart, GermanyGuangdong Province Key Laboratory, Southern China Institute of Large Animal Models for Biomedicine, School of Pharmacy and Food Engineering, Wuyi University, Jiangmen, ChinaInstitute of Cytology, Almazov National Medical Research Centre, Saint-Petersburg, Russia
Edited and Reviewed by: Junjie Xiao, Shanghai University, China
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
atherosclerosisinnate & adaptive immunitycalcific aortic stenosismedial arterial calcificationcohort analysisanimal modelatherosclerosis—diagnosissection-at-acceptanceGeneral Cardiovascular MedicineEditorial on the Research TopicProven and innovative methods of ex vivo examination of atherosclerotic and aortic valve lesions
Unravelling the mysteries of atherosclerosis and its sequelae still remains a pressing issue due to the ongoing health and economic damage. Thereby, atherosclerosis research employs a diverse array of methodological approaches, each contributing unique insights into the disease's pathophysiology, risk factors, and potential treatments. Advanced sequencing techniques, imaging methods, multi-omics approaches, systems biology, machine learning, animal models, and large-scale epidemiological studies collectively enhance our understanding and management of atherosclerosis. These methodologies, when integrated, offer a comprehensive framework for advancing atherosclerosis research and improving clinical outcomes. The present research topic provides a cross section of them by drawing a bow from basic research over diagnostic tools to statistical approaches. The contributions are balanced and consist of three review articles and three original research contributions. The review “Molecular and cellular mechanisms of inflammation in atherosclerosis” by Popa-Fotea et al. provides a comprehensive overview of both innate and adaptive immunity being involved in the inflammatory component of atherosclerosis having the potential to open new therapeutic perspectives. However, since “the gods have placed the diagnosis before the therapy” (Carl Gustav Jung), and atherosclerosis remains asymptomatic for many years, the available diagnostic procedures hold fundamental importance. This is where the excellent review article by Poznyak et al. comes into play describing the most common and effective methods for diagnosing atherosclerosis by covering a wide range from structural and functional imaging of atherosclerosis to molecular methods and biomechanical analysis. The third pleasant review by Kim and Guzman addresses a rare but pathophysiologically intriguing entity, the medial arterial calcification (MAC). It particularly highlights the similarities and differences with atherosclerosis in terms of epidemiology, pathophysiology, and therapeutic approaches.
The keyword “calcification” serves as a bridge to now move to the original research contributions. First of all, Kachanova et al. present an innovative method with promising therapeutic implications matching perfectly our research topic title: a reproducible ex vivo tissue model for human aortic valve calcification. This experimental model includes the three-layered structure of the aortic valve, an architecture that is absent in almost all animal models and thus preserves interactions between cell populations and the extracellular matrix. The quality of the model is demonstrated using the specific Notch inhibitor Crenigacestat (LY30394478).
Next, Witzel et al. used the proven methodology of a sophisticated animal model demonstrating elegantly the impact of pituitary adenylate cyclase-activating polypeptide (PACAP), an anti-atherogenic neuropeptide on inflammatory processes and lipid homeostasis in different macrophage (MΦ) subtypes.
In another article, Peng et al. finally address one of the sequelae of atherosclerosis burden in the broadest sense by an age-period-cohort analysis of the 2019 Global Burden of Disease Study investigating differences in global, regional, and national time trends in disability-adjusted life years for atrial fibrillation and flutter (AF/AFL) The analysis shows that this disease plays a significant and increasing role worldwide withe the burden differing depending on socio-demographic index (SDI).
The present Research Topic will illustrate how methodology accounts for our understanding (and possibly misunderstanding) of the pathogenesis of two fundamental diseases with high impact on global health. It underscores the importance of comprehensive and critical assessments to clearly define the drawbacks and opportunities of the different methods and models. Alternatively, innovative new methodological approaches might broaden one's horizon with regard to fundamental questions regarding atherosclerosis and aortic valve sclerosis.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.